CASR and ovarian carcinoma: Moreover, we also found that high expression of CaSR was associated with a worse prognosis following chemotherapy in breast cancer patients who did not receive endocrine therapy (Fig. S2A) and in ovarian cancer patients who underwent suboptimal debulking surgery (Fig. S2B).